Clinical Trial Update: Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing Moxidectin plus Albendazole versus Ivermectin plus Albendazole for helminth infections; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascariasis
• Hookworm Infection
• Trichuriasis

Drugs mentioned

• Ivermectin/Albendazole combination (Ivermectin + Albendazole)
• Moxidectin/Albendazole combination (Moxidectin + Albendazole)

Snippet

Sponsor: Jennifer Keiser | Conditions: Trichuriasis, Ascariasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-12-05